|
|
|
|
Vol. 52, Issue 6, 948-957, 1997
Sealy Center for Molecular Science (J.K.H.) and
Department of Physiology and Biophysics (J.K.H., G.A.A., A.F.C.),
University of Texas Medical Branch, Galveston, Texas 77555, Department
of Studies in Chemistry, University of Mysore, Mysore-570006, India
(K.N.T., G.K.G.), and
Department of Molecular Pharmacology, St. Jude
Children's Research Hospital, Memphis, Tennessee 38101 (G.S.G.,
P.J.H.)
Novel compounds, composed of two acridone moieties connected by a
propyl or butyl spacer, were synthesized and tested as potential modulators of P-glycoprotein (P-gp)-mediated multidrug resistance. The
propyl derivative 1,3-bis(9-oxoacridin-10-yl)-propane (PBA) was
extremely potent and, at a concentration of 1 µM,
increased steady state accumulation of vinblastine (VLB)
9-fold in
the multidrug-resistant cell line KB8-5. In contrast to the readily reversible effects of VRP and cyclosporin A on VLB uptake and similar
to the effects of the cyclosporin analog PSC 833, this modulation by
PBA was not fully reversed 6-8 hr after transfer of cells to PBA-free
medium. Continuous exposure to 3 µM PBA was nontoxic and
could completely reverse VLB resistance in KB8-5 cells. Consistent
with its effects on VLB transport, the drug resistance-modulating
effect of PSC 833 was significantly more persistent than that of VRP.
However, the effect of PBA was, like that of VRP, rapidly reversed once
the modulator was removed from the extracellular environment. PBA was
able to compete with radiolabeled azidopine for binding to P-gp and to
stimulate P-gp ATPase activity. However, both the steady state
accumulation of PBA and the rate of efflux of PBA were similar in
drug-sensitive KB3-1 and drug-resistant KB8-5 cells, suggesting that
this compound is not efficiently transported by P-gp. These results
indicate that PBA represents a new class of potent and poorly
reversible synthetic modulators of P-gp-mediated VLB transport.